India and the European Union plan to meet on Jan. 18 in Brussels to restart talks on the EU ban of 700 drugs that were tested by Hyderabad-based GVK Biosciences. India said officials from the commerce ministry and the country's Pharmaceuticals Export Promotion Council will travel to Brussels, where "several issues are likely to come up during the meeting, including GVK Biosciences," one official said. The EU ban on the drugs led India to call off trade talks on the Broadbased Trade and Investment Agreement, and India said it was "disappointed" in the ban and also took issue with claims by European investigators at the way the tests were performed. The ban was said to have threatened $1 billion in Indian exports to the EU by March 2016. Report